CRTCE

Braxia Scientific (BRAX.C) announced they will be conducting a randomized clinical trial that will involve giving patients multiple doses of psilocybin. Braxia says this is Canada’s first psilocybin trial…
Braxia Scientific’s (BRAX.C) CEO Dr. Roger McIntyre and Chief Medical and Scientific Officer Dr. Josh Rosenblat have received $918,000 from the Canadian Institutes of Health Research (CIHR), the Government of Canada’s federal funding agency…
Braxia Scientific (BRAX.C) announced that they have established direct billing practices with Medavie Blue Cross for qualifying Canadian military veterans. This agreement is significant because it will allow 100%…